Antidepressant-induced insomnia: Treatment options

Perspectives in Psychiatric Care

Volumn 40, Issue 1, 2004, Pages 29-33

  Antai Otong, Deborah ^a  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Depression; Insomnia; Sleep disturbance

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CHLORDIAZEPOXIDE; DOPAMINE RECEPTOR BLOCKING AGENT; DULOXETINE; ESCITALOPRAM; FLUOXETINE; HYPNOTIC AGENT; MIRTAZAPINE; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VENLAFAXINE;

COMORBIDITY; DECISION MAKING; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG TOLERABILITY; DRUG USE; EVALUATION; HUMAN; HYPNOSIS; INSOMNIA; MAJOR DEPRESSION; NEUROPHYSIOLOGY; NURSE; PATIENT CARE; POLYSOMNOGRAPHY; PRESCRIPTION; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; RECURRENT DISEASE; RELAPSE; REM SLEEP; REVIEW; SAFETY; SLEEP; SLEEP DISORDER; SUICIDE; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 2442490594     PISSN: 00315990     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2004.00029.x     Document Type: Review

References (20)

1. Armitage, R. (1996). The effects of antidepressants on sleep in patients with depression. Canadian Journal of Psychiatry, 45, 803-809.
2. Buysse, D.J., Frank, E., Lowe, K.K., Cherry, C.R., & Kupfer, D.J. (1997). Electroencephalographic sleep correlates of episode and vulnerability to recurrence depression. Biological Psychiatry, 41, 406-418.
3. Buysse, D.J., Reynolds, C.F., II, Monk, T.H., Berman, S.R., & Kupfer, D.J. (1989). The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research, 28, 193-213.
4. Dorsey, C.M., Lukas, S.E., & Cunningham, S.L. (1996). Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology, 14, 437-442.
5. Innerarity, S.A. (2003). The client with a sleep disorder. In D. Antai-Otong (Ed.), Psychiatric nursing: Biological and behavioral concepts (pp. 611-630). Clifton Parks, NY: Delmar Thomson Learning.
6. Maes, M., Meltzer, H.Y., Suy, E., Minner, B., Calabres, J., & Cosyns, P. (1993). Sleep disorders and anxiety as symptom profiles of sympathoadrenal system hyperactivity in major depression. Journal of Affective Disorders, 27, 197-207.
7. Ott, G.E., Rao, U., Nuccio, I., Lin, K.M., & Poland, R.E. (2002). Effect of bupropion-SR on REM sleep: Relationship to antidepressant response. Psychopharmacology, 165, 29-36.
8. Pinder, R.M. (1997). The pharmacology of mirtazapine. Journal of Clinical Psychiatry, 58, 501-502.
9. Riemann, D., Berger, M., & Voderholzer, U. (2001). Sleep and depression - Results from psychobiological studies: An overview. Biological Psychiatry, 57, 67-103.
10. Rush, J.A., Armitage, R., Gillin, J.C., Yonkers, K.A., Winokur, A., Moldofsky, H., et al. (1998). Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biological Psychiatry, 44, 3-14.
11. Sateia, M.J. (2002). Epidemiology, consequences, and evaluation of insomnia. In T.L. Lee-Ciong Jr, M.J. Sateia, & M.A. Carskadon (Eds), Sleep medicine (pp. 151-160). Philadelphia: Hanley & Belfus.
12. Schenck, C.H., Mahowald, M.W., & Sack, R.L. (2003). Assessment and management of insomnia. JAMA, 289, 2475-2479.
13. Schittecatte, M., Dumont, F., Machowski, R., Cornil, C., Lavergne, F., & Wilmotte, J. (2002). Effects of mirtazapine on sleep polygraphic variables in major depression. Neuropsychobiology, 46, 197-201.
14. Simon, G.E., & VonKorff, M. (1997). Prevalence, burden, and treatment of insomnia in primary care. American Journal of Psychiatry, 154, 1417-1423.
15. Thase, M.E. (1998). Depression, sleep, and antidepressants. Journal of Clinical Psychiatry, 59(Suppl. 4), 55-65.
16. Thase, M.E. (2000). Treatment issues related to sleep and depression. Journal of Clinical Psychiatry, 62(Suppl. 11), 46-50.
17. Thase, M.E., & Howland, R.H. (1995). Biological processes in depression: An updated review and integration. In E.E. Beckham & W.R. Leber (Eds.), Handbook of depression (pp. 213-279). New York Guilford Press.
18. Thase, M.E., Simons, A.D., & Reynolds, C.F., III. (1996). Abnormal electroencephalographic sleep profiles in major depression: An association with response to cognitive behavior therapy. Archives of General Psychiatry, 53, 99-108.
19. Winokur, A., Gary, K.A., Rodner, S., Rae-Red, C., Fernando, A.T., & Szuba, M.P. (2001). Depression, sleep physiology, and antidepressant drugs. Depression and Anxiety, 14, 19-28.
20. Winokur, A., Sateia, M.J., Hayes, B., Bayles-Dazet, W., MacDonald, M.M., & Gary, K.A. (2000). Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: A pilot study. Biological Psychiatry, 48, 75-78.